Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:33 PM
Ignite Modification Date:
2025-12-24 @ 11:33 PM
NCT ID:
NCT06286956
Eligibility Criteria:
Inclusion Criteria:
* All polyps included in the Paris Classification (Polypoid (0-I): Sessile type (Is), Pedunculated type (Ip), Non-polypoid (0-II, III): Raised type (IIa), Flat type (IIb), Depressed type (IIc), Excavated type (III))
* Lesions located from the anal margin to about 20 cm.
* Extent of at least 2 cm² (polyps 2 cm in diameter or areas of ERM or ESD 2 x 2 cm).
* Well or moderately differentiated tumours. T1: Tumours confined to the mucosa (Tis) and submucosa (T1).
* No positive lymph nodes.
* No lymphatic, vascular or perineural invasion.
Exclusion Criteria:
* Are considered vulnerable subjects.
* They suffer from hematological diseases with altered coagulation of their own or pharmacologically induced coagulation disorders (the use of acetylsalicylic acid (ASA) in doses of 150 mg/day is permitted).
* Have rectal lesions that lie above the pectineal line or extend into the anal canal.
* Local or distant metastasis.
* Have a score of more than 2 points on the Wexner faecal incontinence scale.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06286956
Study Brief:
Protocol Section:
NCT06286956